Anton Svendrovski

Mr. Anton Svendrovski

UZIK Consulting Inc.
orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2020 in BMJ
Verified
Journal Article
Open access
PDF file
LGLong Ge
Long Ge
Behnam SadeghiradBehnam Sadeghirad
Behnam Sadeghirad
GBGeoff D C Ball
Geoff D C Ball
BCBruno R da Costa
Bruno R da Costa
CHChristine L Hitchcock
Christine L Hitchcock
BJBradley Johnston
Bradley Johnston
Objective: To determine the relative effectiveness of dietary macronutrient patterns and popular named diet programmes for weight loss and cardiovascular risk factor improvement among adults who are overweight or obese. Design: Systematic review and network meta-analysis of randomised trials. Data sources: Medline, Embase, CINAHL, AMED, and CENTRAL from database inception until September 2018, reference lists of eligible trials, and related reviews. Study selection: Randomised trials that enrolled adults (≥18 years) who were overweight (body mass index 25-29) or obese (≥30) to a popular named diet or an alternative diet. Outcomes and measures: Change in body weight, low density lipoprotein (LDL) cholesterol, high density lipoprotein (HDL) cholesterol, systolic blood pressure, diastolic blood pressure, and C reactive protein at the six and 12 month follow-up. Review methods: Two reviewers independently extracted data on study participants, interventions, and outcomes and assessed risk of bias, and the certainty of evidence using the GRADE (grading of recommendations, assessment, development, and evaluation) approach. A bayesian framework informed a series of random effects network meta-analyses to estimate the relative effectiveness of the diets. Results: 121 eligible trials with 21 942 patients were included and reported on 14 named diets and three control diets. Compared with usual diet, low carbohydrate and low fat diets had a similar effect at six months on weight loss (4.63 v 4.37 kg, both moderate certainty) and reduction in systolic blood pressure (5.14 mm Hg, moderate certainty v 5.05 mm Hg, low certainty) and diastolic blood pressure (3.21 v 2.85 mm Hg, both low certainty). Moderate macronutrient diets resulted in slightly less weight loss and blood pressure reductions. Low carbohydrate diets had less effect than low fat diets and moderate macronutrient diets on reduction in LDL cholesterol (1.01 mg/dL, low certainty v 7.08 mg/dL, moderate certainty v 5.22 mg/dL, moderate certainty, respectively) but an increase in HDL cholesterol (2.31 mg/dL, low certainty), whereas low fat (−1.88 mg/dL, moderate certainty) and moderate macronutrient (−0.89 mg/dL, moderate certainty) did not. Among popular named diets, those with the largest effect on weight reduction and blood pressure in comparison with usual diet were Atkins (weight 5.5 kg, systolic blood pressure 5.1 mm Hg, diastolic blood pressure 3.3 mm Hg), DASH (3.6 kg, 4.7 mm Hg, 2.9 mm Hg, respectively), and Zone (4.1 kg, 3.5 mm Hg, 2.3 mm Hg, respectively) at six months (all moderate certainty). No diets significantly improved levels of HDL cholesterol or C reactive protein at six months. Overall, weight loss diminished at 12 months among all macronutrient patterns and popular named diets, while the benefits for cardiovascular risk factors of all interventions, except the Mediterranean diet, essentially disappeared. Conclusions: Moderate certainty evidence shows that most macronutrient diets, over six months, result in modest weight loss and substantial improvements in cardiovascular risk factors, particularly blood pressure. At 12 months the effects on weight reduction and improvements in cardiovascular risk factors largely disappear. Systematic review registration: PROSPERO CRD42015027929.

13 August 2018 in Journal of Neuroimaging
Verified
Journal Article
Closed access
PDF file
CCCourtney Casserly
Courtney Casserly
ESEstelle Seyman
Estelle Seyman
PAPaula Alcaide‐Leon
Paula Alcaide‐Leon
MGMelanie Guenette
Melanie Guenette
CLCarrie E Lyons
Carrie E Lyons
JOJiwon Oh
Jiwon Oh

23 April 2014 in Journal of Alzheimer’s Disease
Verified
Journal Article
Open access
PDF file
Rónán O'CaoimhRónán O'Caoimh
Rónán O'Caoimh
LHLiam Healy
Liam Healy
YGYang Gao
Yang Gao
Anton SvendrovskiAnton Svendrovski
Anton Svendrovski
DKDavid M. Kerins
David M. Kerins
DMD. William Molloy
D. William Molloy
Background: Centrally acting angiotensin converting enzyme inhibitors (CACE-Is) are associated with reduced rates of cognitive decline in patients with dementia. CACE-Is may also improve exercise tolerance in functionally impaired older adults with n

19 September 2014 in BMC Geriatrics
Verified
Journal Article
Open access
PDF file
Rónán O'CaoimhRónán O'Caoimh
Rónán O'Caoimh
YGYang Gao
Yang Gao
Anton SvendrovskiAnton Svendrovski
Anton Svendrovski
EHElizabeth Healy
Elizabeth Healy
EOElizabeth O’connell
Elizabeth O’connell
DMDavid William Molloy
David William Molloy
Functional decline and frailty are common in community dwelling older adults, increasing the risk of adverse outcomes. Given this, we investigated the prevalence of frailty-associated risk factors and their distribution according to the severity of perceived risk in a cohort of community dwelling older adults, using the Risk Instrument for Screening in the Community (RISC). A cohort of 803 community dwelling older adults were scored for frailty by their public health nurse (PHN) using the Clinical Frailty Scale (CFS) and for risk of three adverse outcomes: i) institutionalisation, ii) hospitalisation and iii) death, within the next year, from one (lowest) to five (highest) using the RISC. Prior to scoring, PHNs stated whether they regarded patients as frail. The median age of patients was 80 years (interquartile range 10), of whom 64% were female and 47.4% were living alone. The median Abbreviated Mental Test Score (AMTS) was 10 (0) and Barthel Index was 18/20 (6). PHNs regarded 42% of patients as frail, while the CFS categorized 54% (scoring ≥5) as frail. Dividing patients into low-risk (score one or two), medium-risk (score three) and high-risk (score four or five) using the RISC showed that 4.3% were considered high risk of institutionalization, 14.5% for hospitalization, and 2.7% for death, within one year of the assessment. There were significant differences in median CFS (4/9 versus 6/9 versus 6/9, p < 0.001), Barthel Index (18/20 versus 11/20 versus 14/20, p < 0.001) and mean AMTS scores (9.51 versus 7.57 versus 7.00, p < 0.001) between those considered low, medium and high risk of institutionalisation respectively. Differences were also statistically significant for hospitalisation and death. Age, gender and living alone were inconsistently associated with perceived risk. Frailty most closely correlated with functional impairment, r = −0.80, p < 0.001. The majority of patients in this community sample were perceived to be low risk for adverse outcomes. Frailty, cognitive impairment and functional status were markers of perceived risk. Age, gender and social isolation were not and may not be useful indicators when triaging community dwellers. The RISC now requires validation against adverse outcomes.

18 July 2016 in International Journal of Geriatric Psychiatry
Verified
Journal Article
Closed access
PDF file
RCRoger Clarnette
Roger Clarnette
Rónán O'CaoimhRónán O'Caoimh
Rónán O'Caoimh
DADeanna N. Antony
Deanna N. Antony
Anton SvendrovskiAnton Svendrovski
Anton Svendrovski
DMD. William Molloy
D. William Molloy

20 April 2017 in American Journal of Alzheimer's Disease and Other Dementias®
Verified
Journal Article
Closed access
BDBurcu Balam Dogu
Burcu Balam Dogu
HVHacer Dogan Varan
Hacer Dogan Varan
Rónán O'CaoimhRónán O'Caoimh
Rónán O'Caoimh
MKMuhammet Cemal Kizilarslanoglu
Muhammet Cemal Kizilarslanoglu
MKMustafa Kemal Kilic
Mustafa Kemal Kilic
MCMustafa Cankurtaran
Mustafa Cankurtaran
The objective of this study was to validate the Turkish version of the Quick Mild Cognitive Impairment (Qmci-TR) screen. In total, 100 patients aged ≥65 years referred to a geriatric outpatient clinic with memory loss were included. The Qmci was compared to the Turkish versions of the standardized Mini-Mental State Examination and the Montreal Cognitive Assessment (MoCA). The Qmci-TR had higher accuracy than the MoCA in discriminating subjective memory complaints (SMCs) from cognitive impairment (mild cognitive impairment [MCI] or dementia), of borderline significance after adjusting for age and education (P = .06). The Qmci-TR also had higher accuracy than the MoCA in differentiating MCI from SMC, which became nonsignificant after adjustment (P = .15). A similar pattern was shown for distinguishing MCI from dementia. Test reliability for the Qmci-TR was strong. The Qmci-TR is a reliable and useful screening tool for discriminating MCI from SMC and dementia in a Turkish population.